These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock. While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight. That said, let's delve into the average estimates of some Steris metrics that Wall Street analysts commonly model and monitor. Analysts' assessment points toward 'Revenues- Healthcare' reaching $950.73 million. The estimate indicates a year-over-year change of +9.3%. Based on the collective assessment of analysts, 'Revenues- Healthcare Products- Service' should arrive at $342.16 million. The estimate points to a change of +10.7% from the year-ago quarter.